» Articles » PMID: 31011484

Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer's Disease

Overview
Journal Aging Dis
Specialty Geriatrics
Date 2019 Apr 24
PMID 31011484
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a complex, multifactorial disease involving many pathological mechanisms. Nonetheless, single pathogenic mutations in amyloid precursor protein (APP) or presenilin 1 or 2 can cause AD with almost all of the clinical and neuropathological features, and therefore, we believe an important mechanism of pathogenesis in AD could be revealed from examining pathogenic APP missense mutations. A comprehensive review of the literature, including clinical, neuropathological, cellular and animal model data, was conducted through PubMed and the databases of Alzforum mutations, HGMD, UniProt, and AD&FTDMDB. Pearson correlation analysis combining the clinical and neuropathological data and aspects of mutant APP processing in cellular models was performed. We find that an increase in Aβ42 has a significant positive correlation with the appearance of neurofibrillary tangles (NFTs) and tends to cause an earlier age of AD onset, while an increase in Aβ40 significantly increases the age at death. The increase in the α-carboxyl terminal fragment (CTF) has a significantly negative correlation with the age of AD onset, and β-CTF has a similar effect without statistical significance. Animal models show that intracellular Aβ is critical for memory defects. Based on these results and the fact that amyloid plaque burden correlates much less well with cognitive impairment than do NFT counts, we propose a "snowball hypothesis": the accumulation of intraneuronal NFTs caused by extracellular Aβ42 and the increase in intraneuronal APP proteolytic products (CTFs and Aβs) could cause cellular organelle stress that leads to neurodegeneration in AD, which then resembles the formation of abnormal protein "snowballs" both inside and outside of neurons.

Citing Articles

Aging as a target for the prevention and treatment of Alzheimer's disease.

Yap L, Hunt J, Turner R Front Neurol. 2024; 15:1376104.

PMID: 38645748 PMC: 11027067. DOI: 10.3389/fneur.2024.1376104.


Activation of autophagy by Citri Reticulatae Semen extract ameliorates amyloid-beta-induced cell death and cognition deficits in Alzheimer's disease.

Tang Y, Wei J, Wang X, Long T, Xiang X, Qu L Neural Regen Res. 2024; 19(11):2467-2479.

PMID: 38526283 PMC: 11090445. DOI: 10.4103/NRR.NRR-D-23-00954.


Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer's Disease.

Pantelopulos G, Abraham C, Straub J Annu Rev Biophys. 2024; 53(1):455-486.

PMID: 38382114 PMC: 11575466. DOI: 10.1146/annurev-biophys-062823-023436.


Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's disease related proteins.

Oatman S, Reddy J, Quicksall Z, Carrasquillo M, Wang X, Liu C Mol Neurodegener. 2023; 18(1):2.

PMID: 36609403 PMC: 9825010. DOI: 10.1186/s13024-022-00592-2.


Key Residue for Aggregation of Amyloid-β Peptides.

Itoh S, Yagi-Utsumi M, Kato K, Okumura H ACS Chem Neurosci. 2022; 13(22):3139-3151.

PMID: 36302506 PMC: 9673141. DOI: 10.1021/acschemneuro.2c00358.


References
1.
Lemere C, Blusztajn J, Yamaguchi H, Wisniewski T, Saido T, Selkoe D . Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis. 1996; 3(1):16-32. DOI: 10.1006/nbdi.1996.0003. View

2.
Morelli L, Llovera R, Gonzalez S, Affranchino J, Prelli F, Frangione B . Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme. J Biol Chem. 2003; 278(26):23221-6. DOI: 10.1074/jbc.M300276200. View

3.
Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M . beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci U S A. 2001; 98(21):12245-50. PMC: 59799. DOI: 10.1073/pnas.211412398. View

4.
Tamaoka A, Odaka A, Ishibashi Y, Usami M, Sahara N, Suzuki N . APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brain. J Biol Chem. 1994; 269(52):32721-4. View

5.
Levy E, Marder K, Frangione B . Codon 618 variant of Alzheimer amyloid gene associated with inherited cerebral hemorrhage. Ann Neurol. 1991; 30(5):730-3. DOI: 10.1002/ana.410300516. View